|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1990-11-6
|
|
pubmed:abstractText |
The data from this study indicate that cefoxitin was effective and generally well tolerated in the management of gangrenous and/or perforated appendicitis. No strong correlation was identified between in vitro susceptibility testing results and clinical outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
8750-2836
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25 Suppl 4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2120270-Appendicitis,
pubmed-meshheading:2120270-Bacteroides fragilis,
pubmed-meshheading:2120270-Cefoxitin,
pubmed-meshheading:2120270-Ceftizoxime,
pubmed-meshheading:2120270-Double-Blind Method,
pubmed-meshheading:2120270-Gangrene,
pubmed-meshheading:2120270-Humans,
pubmed-meshheading:2120270-Intestinal Perforation,
pubmed-meshheading:2120270-Microbial Sensitivity Tests,
pubmed-meshheading:2120270-Prospective Studies,
pubmed-meshheading:2120270-Rupture, Spontaneous
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Gangrenous and/or perforated appendix: clinical outcome and in vitro susceptibility testing.
|
|
pubmed:affiliation |
University of California, Los Angeles.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
